Skip to main content

MINI REVIEW article

Front. Disaster Emerg. Med.
Sec. Resuscitation and Cardiac Emergency Medicine
Volume 2 - 2024 | doi: 10.3389/femer.2024.1374291
This article is part of the Research Topic

Recent Advances in Emergency Medicine

View all Articles

Advances and Challenges in Mechanical Support for Cardiogenic Shock complicating Acute Myocardial Infarct: A Comprehensive Review of the Latest Data Provisionally Accepted

Amalia Papanikolaou1 David Dimitris Chlorogiannis2* Anastasios Apostolos1, 3 Theodoros Mavridis4, 5 Grigorios Tsigkas1
  • 1Department of Cardiology, University Hospital of Patras, Greece
  • 2Brigham and Women's Hospital, Harvard Medical School, United States
  • 3National and Kapodistrian University of Athens, Greece
  • 4Eginition Hospital, Greece
  • 5Department of Neurology, Tallaght University Hospital, Ireland

The final, formatted version of the article will be published soon.

Receive an email when it is updated
You just subscribed to receive the final version of the article

Cardiogenic Shock represents a life-threatening condition characterized by high mortality and a spectrum of clinical presentations, complicating approximately 5-10% of patients presenting with Acute Coronary Syndromes. Despite advances in interventional cardiology and emergency medicine, mortality rates remain extremely high and evidence concerning its management is scarce. Consequently, the decision making relies heavily on a single operator's experience. This comprehensive review aims to provide a thorough update on the latest proof regarding mechanical circulatory support devices of the left ventricle and examines the role of the classification scores on the selection of the appropriate patient and timing for the initiation of the device.

Keywords: Cardiogenic shock, Mechanical circulation support, CS, Impella, VA-ECMO

Received: 21 Jan 2024; Accepted: 13 May 2024.

Copyright: © 2024 Papanikolaou, Chlorogiannis, Apostolos, Mavridis and Tsigkas. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Dr. David Dimitris Chlorogiannis, Brigham and Women's Hospital, Harvard Medical School, Boston, 02115, Massachusetts, United States